Your Navigation:PCAR > Abstract
Search pcar
检索项:
检索词:
Abstract
Pharmaceutical Care and Research: 2019; 19(1):9,15,24,71
DOI: 10.5428/pcar20190103
Pharmaceutical care of the patients with coronary artery bypass surgery in anti-platelet treatment during peri-operative period
1. WU Danna(a wudannachangchang@163.com)
2. HAN Fangxuan(a hfx1223@163.com)
Welcome to PCAR! You are the number 209 reader of this article!
Please cite this article as:
WU Danna,HAN Fangxuan,. Pharmaceutical care of the patients with coronary artery bypass surgery in anti-platelet treatment during peri-operative period[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2019; 19(1): 9,15,24,71.
References:
1. Barua R S,Ambrose J A.Mechanisms of coronary thrombosis in cigarette smoke exposure[J].Arterioscler Thromb Vasc Biol,2013,33(7):1460-1467.
2. Myles P S,Smith J A,Forbes A,et al.Stopping vs.continuing aspirin before coronary artery surgery[J].N Engl J Med,2016,374(8):728-737.
3. Guyatt G H,Akl E A,Crowther M,et al.Executive summary: antithrombotic therapy and prevention of thrombosis 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines[J].Chest,2012,141(2 Suppl):7S-47S.
4. Douketis J D,Spyropoulos A C,Spencer F A,et al.Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines[J].Chest,2012,141(2 Suppl):e326S-e350S.
5. WU Hengchao,WANG Jian,SUN Hansong,et al.Preoperative continuation of aspirin therapy may improve perioperative saphenous venous graft patency after off-pump coronary artery bypass grafting[J].Ann Thorac Surg,2015,99(2):576-581.
6. JIA Yuanfang,ZHANG Xuejuan,GUO Junjie.Clinical use in cardiovascular disease of thrombelastogram[J].Adv Cardiovasc Dis,2015,36(2):207-210.In Chinese with English abstract.
7. Kulik A,Ruel M,Jneid H,et al.Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American Heart Association[J].Circulation,2015,131(10):927-964.
8. Gaubert M,Laine M,Richard T,et al.Effect of ticagrelor-related dyspnea on compliance with therapy in acute coronary syndrome patients[J].Int J Cardiol,2014,173(1):120-121.
9. Cherepanov V,Fortmann S D,Hyun Kim M,et al.Annual adverse event profiles after clopidogrel,prasugrel,and ticagrelor in the Food and Drug Administration Adverse Event Reporting System[J].Eur Heart J Cardiovasc Pharmacother,2018,4(2):69-71.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330
·电子邮件:PharmCR@vip.163.com
·技术支持:中国康网
管理员入口